2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 213 funds opening new positions, 1,177 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,177 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.1%65.94% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,865
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2551
$215K
2552
$215K
2553
$214K
2554
$213K
2555
$213K
2556
$212K
2557
$212K
2558
$211K
2559
$211K
2560
$211K
2561
$210K
2562
$210K
2563
$209K
2564
$209K
2565
$209K
2566
$208K
2567
$208K
2568
$208K
2569
$208K
2570
$208K
2571
$207K
2572
$206K
2573
$206K
2574
$206K
2575
$206K